Omega-3 for Joint Pain: Fish Oil, Krill Oil, and What the Evidence Shows

Last updated: July 14, 2026  |  By Richard Hale

Omega-3 fatty acids appear in most conversations about joint health, and the clinical evidence backs up why. But the details matter more than most supplement discussions acknowledge. Fish oil and krill oil are not interchangeable products. The dosing question is less intuitive than supplement labels suggest. And the strength of the evidence varies considerably depending on which joint condition you are dealing with. This article covers what the research actually shows about omega-3 for joint pain, what separates fish oil from krill oil for articular joint problems specifically, how much you need, and where omega-3 fits within a broader approach to joint nutrition after 40.

Content is educational and not a substitute for advice from a qualified healthcare provider.

Table of Contents

1. How Omega-3 Reduces Joint Inflammation
2. Fish Oil vs Krill Oil: The Form Matters
3. What the Clinical Evidence Shows
4. The Dose Question
5. Food Sources vs Supplements
6. What to Look for When Buying
7. How Omega-3 Fits with Other Joint Nutrients
8. Frequently Asked Questions

How Omega-3 Reduces Joint Inflammation

EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are the two omega-3 fatty acids with direct biological activity in human tissue. They are structural components of cell membranes, and their presence changes how those cells respond to inflammatory signals.

The standard explanation is that omega-3s compete with omega-6 fatty acids (particularly arachidonic acid) for the same enzymes. Omega-6 fats, when metabolised by cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, produce prostaglandins and leukotrienes that amplify inflammatory responses. Omega-3s occupy the same metabolic pathway but produce weaker pro-inflammatory signals, effectively diluting the inflammatory response.

But the more interesting mechanism, and the one that has driven most of the recent clinical interest, is that EPA and DHA are precursors to a class of molecules called specialised pro-resolving mediators (SPMs). These include resolvins (primarily from EPA) and protectins (primarily from DHA). SPMs do not simply suppress inflammation passively; they actively promote the resolution phase, clearing inflammatory debris and signalling tissue to return to a resting state. In joint tissue specifically, SPMs downregulate NF-kB activity, reduce synovial lining inflammation, and support chondrocyte survival, which is relevant because chondrocytes are the cells responsible for maintaining cartilage matrix.

This resolution mechanism is distinct from the mechanisms of other anti-inflammatory supplements. Boswellia inhibits the 5-LOX enzyme. Curcumin targets COX-2. MSM reduces oxidative stress and NF-kB signalling. Omega-3 SPMs act downstream of all of these, at the resolution phase rather than the initiation phase.

Fish Oil vs Krill Oil: The Form Matters

Both fish oil and krill oil provide EPA and DHA. The difference is the molecular form in which those fatty acids are delivered.

Standard fish oil delivers EPA and DHA as triglycerides. The omega-3 fatty acids are esterified onto a glycerol backbone, which is how most dietary fats are structured. Some premium fish oils use a re-esterified triglyceride (rTG) form that concentrates EPA and DHA to higher percentages, but the structural form is the same.

Krill oil delivers EPA and DHA primarily as phospholipids. This is structurally similar to the form in which omega-3s are incorporated into cell membranes, and there is evidence that phospholipid-bound omega-3s are absorbed more efficiently than triglyceride forms, meaning a smaller gram dose of krill oil may deliver comparable active EPA+DHA to a larger dose of standard fish oil. Krill oil also contains astaxanthin, a carotenoid antioxidant with direct anti-inflammatory activity that is not present in fish oil.

The phospholipid absorption advantage is real but should not be overstated. Most of the data comes from comparison studies measuring EPA and DHA in blood plasma or red blood cell membranes after supplementation, and results vary depending on what the supplement is taken with, individual gut function, and baseline EPA and DHA status. What matters clinically is not which form has the edge in absorption studies, but which products have demonstrated benefit in joint-specific trials.

That is where krill oil currently has the stronger position for osteoarthritis specifically.

What the Clinical Evidence Shows

Krill oil and knee osteoarthritis

The most directly relevant clinical trial is Stonehouse et al. 2022, published in the American Journal of Clinical Nutrition. This was a 6-month, randomised, double-blind, placebo-controlled trial in 235 adults with mild to moderate knee osteoarthritis. Participants received either 4g of krill oil per day (providing 0.60g EPA, 0.28g DHA, and 0.45mg astaxanthin) or placebo (mixed vegetable oil).

Knee pain scores improved in both groups, but improvements were significantly greater in the krill oil group across all three WOMAC domains: pain (p=0.04), stiffness (p<0.05), and physical function (p<0.05). The differences were modest in absolute terms, with WOMAC score improvements of around 5 to 7 points between groups, but the consistency across all three domains, over 6 months, in a properly controlled trial is meaningful for a nutritional intervention.

The study used Superba2 krill oil by Aker BioMarine, which is also the ingredient behind several commercial krill oil brands. The dose used, 4g per day, is higher than what most consumer products deliver per serving, which is relevant when evaluating the practical translation of the trial results.

Fish oil and rheumatoid arthritis

Fish oil has a longer and better-documented clinical record in rheumatoid arthritis (RA). A 2013 review by Calder, covering more than 13 RCTs, found consistent evidence that fish oil supplementation reduces joint tenderness count, morning stiffness duration, and patient-reported pain in RA. Several trials showed reductions in NSAID or DMARD requirements in fish oil groups. The mechanism is consistent with EPA and DHA reducing the leukotriene and prostaglandin load that drives RA inflammation.

The distinction between RA and osteoarthritis is important here. RA is primarily an autoimmune condition with inflammatory joint destruction as a secondary consequence. OA is primarily degenerative, with inflammatory amplification as a secondary factor. Omega-3 address the inflammatory component in both conditions, but the clinical trial record is stronger for RA (fish oil) and for knee OA specifically (krill oil).

General anti-inflammatory evidence

At a population level, higher dietary omega-3 intake is consistently associated with lower levels of inflammatory markers including C-reactive protein and interleukin-6. These are systemic markers rather than joint-specific, but chronic systemic inflammation is a contributing factor to the progression of both OA and RA in adults over 40.

The Dose Question

This is where many omega-3 supplement labels mislead by omission. A product label stating “1000mg fish oil per capsule” is not the same as “1000mg EPA and DHA per capsule.” Standard fish oil is roughly 30% EPA and DHA by weight, meaning a 1000mg fish oil capsule delivers around 300mg of actual active omega-3 fatty acids. Concentrated fish oils (65-90% EPA+DHA) deliver more per capsule but are priced accordingly.

The Stonehouse krill oil trial used 4g total krill oil per day, which provided 0.88g combined EPA and DHA. This is at the lower end of the dose range associated with joint benefit in fish oil studies, likely because of the phospholipid absorption advantage.

For fish oil, the evidence-based dose range for joint benefit across the RA literature is approximately 2 to 4g EPA+DHA per day. The NHS recommends at least 1g combined EPA and DHA daily for general cardiovascular benefit. For specific anti-inflammatory joint support, most practitioners suggest 2g EPA+DHA minimum, which may require 6 to 8 standard 1000mg fish oil capsules per day depending on the concentration of the product.

Reading the supplement facts panel to find the EPA and DHA content per serving, not just the total fish oil or krill oil per capsule, is the single most important thing to check when evaluating a product.

Food Sources vs Supplements

It is worth understanding what food alone can realistically deliver, because the dose question changes the food-versus-supplement calculation significantly.

Oily fish are the primary dietary source of EPA and DHA. Approximate omega-3 content per 100g cooked serving:

Two portions of oily fish per week delivers roughly 3 to 5g of EPA and DHA across the week, or 0.4 to 0.7g per day on average. This is below the 2g daily dose associated with anti-inflammatory joint benefit in most trials. Achieving trial-equivalent doses from food alone would require eating oily fish every day, which is impractical and also introduces concerns about mercury and PCB accumulation at high intake frequencies.

Plant sources such as walnuts, flaxseed, and chia seed provide alpha-linolenic acid (ALA), which is a short-chain omega-3. The human body can convert ALA to EPA and DHA, but the conversion rate is inefficient, typically 5 to 10% to EPA and under 1% to DHA in most adults. Plant sources cannot substitute for fish or krill oil when the goal is achieving therapeutic EPA and DHA levels for joint inflammation.

For most adults over 40 with specific joint health goals, supplementation to bridge the gap above dietary intake is the realistic approach.

What to Look for When Buying

The label should clearly state EPA and DHA amounts per serving as separate values, not bundled into a “total omega-3” figure. A product that lists only “omega-3 fatty acids” or “fish oil concentrate” without breaking down EPA and DHA separately cannot be meaningfully compared to the clinical evidence.

For krill oil specifically, look for phospholipid content listed on the label (ideally above 35%), and astaxanthin content (typically 0.1 to 0.5mg per serving in standard products, though the Stonehouse trial used a higher dose). Third-party testing certification, particularly IFOS (International Fish Oil Standards) or equivalent programmes, confirms that the product meets label claims and has been tested for heavy metals, PCBs, and dioxins.

For fish oil, concentrated forms (listed as “concentrated omega-3” or showing EPA+DHA totalling 60% or more of the per-capsule amount) are more efficient per capsule than standard fish oil. Re-esterified triglyceride (rTG) forms may offer better absorption than standard ethyl ester concentrates. Free fatty acid form is generally considered the most bioavailable but is less common in consumer products.

Sustainability certifications (MSC for fish oil, IKOS or similar for krill) are worth checking if sourcing practices matter to you, though they do not directly affect the product’s clinical utility.

How Omega-3 Fits with Other Joint Nutrients

Omega-3 addresses the inflammatory and resolution pathway. It does not directly provide structural support for cartilage, nor does it address the immune-mediated cartilage degradation that is the mechanism behind UC-II collagen’s clinical effect.

A full joint support stack for adults over 40 typically addresses three distinct problems: structural cartilage support (glucosamine, UC-II collagen), active inflammation reduction (boswellia, MSM, omega-3), and cartilage immune protection (UC-II collagen via oral tolerisation). Omega-3 fits the anti-inflammatory tier alongside boswellia and MSM, but through a distinct mechanism, and adding it to a multi-ingredient joint supplement does not produce redundancy since the pathways are different.

For more on the structural and immune mechanisms, see our guides on collagen supplements for joint pain, MSM for joint pain, and boswellia for joint inflammation. For a full overview of what a comprehensive joint supplement stack looks like, including the evidence base for each ingredient category, see our review of the best multi-ingredient joint supplements.

Omega-3 is also frequently taken for cardiovascular benefit, and the joint anti-inflammatory effect comes on top of its established cardiovascular role. For adults managing both priorities, omega-3 is one of the more versatile nutritional supplements in terms of evidence across multiple systems.

Frequently Asked Questions

How long does omega-3 take to help joint pain?

Most clinical trials showing joint benefit use supplementation periods of 3 to 6 months, with statistically significant improvements appearing at the end of the study period rather than early in the trial. EPA and DHA are incorporated into cell membranes over weeks to months, which is why the effects are gradual. Expecting meaningful joint pain relief in the first few weeks of omega-3 supplementation is unlikely to reflect the clinical timeline.

What is the difference between fish oil and krill oil for joint pain?

Fish oil delivers EPA and DHA in triglyceride form and has the strongest clinical evidence for rheumatoid arthritis. Krill oil delivers EPA and DHA in phospholipid form, also provides astaxanthin, and has the most direct clinical trial evidence for knee osteoarthritis (Stonehouse et al. 2022, Am J Clin Nutr). For adults whose joint pain is primarily in cartilage-bearing joints like knees and hips, krill oil is the more specifically evidenced choice. Both are appropriate depending on the available product and dose.

Can I get enough omega-3 for joint benefit from food alone?

Achieving the 2g EPA+DHA daily dose associated with anti-inflammatory joint benefit from food alone would require eating oily fish such as salmon or mackerel every day, which is not practical for most adults and introduces concerns about mercury exposure at that frequency. Supplementing on top of 2 to 3 weekly portions of oily fish is the more realistic approach for adults with specific joint health goals.

Is it safe to take omega-3 with other joint supplements?

There are no known interactions between omega-3 and the commonly used joint supplements such as glucosamine, chondroitin, collagen, MSM, or boswellia. Omega-3 does have mild anticoagulant effects at high doses, so adults taking blood-thinning medications such as warfarin or aspirin should discuss omega-3 supplementation with their healthcare provider before starting. At standard supplement doses of 1 to 4g per day, the anticoagulant effect is typically not clinically significant in otherwise healthy adults.

Is krill oil better than fish oil for joint inflammation?

Krill oil has more direct clinical evidence for knee osteoarthritis specifically, and the phospholipid form may offer absorption advantages at lower gram doses. Fish oil has the larger body of clinical evidence overall, particularly for rheumatoid arthritis. Neither is universally superior; the appropriate choice depends on the type of joint condition, the dose achievable with a given product, and practical factors like cost and availability. Reading EPA and DHA content per serving rather than total oil per capsule is the most important factor when comparing products.

About the author: Richard Hale is an independent health writer focused on mobility, joint health, and active aging research. He is not a licensed medical professional. All content on VitalMove40 is for educational purposes only and is not a substitute for advice from a qualified healthcare provider.